Ki67 is a cellular marker of proliferation whose expression was decreased by the combination treatment after IHC staining, indicating that the combinatory therapy suppressed NSCLC cell proliferation (Fig. 6E). This evidence concerns the gene MKI67 and non-small cell lung carcinoma.